These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33069067)

  • 21. Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands.
    Shi ZD; Wei CQ; Lee K; Liu H; Zhang M; Araki T; Roberts LR; Worthy KM; Fisher RJ; Neel BG; Kelley JA; Yang D; Burke TR
    J Med Chem; 2004 Apr; 47(8):2166-9. PubMed ID: 15056012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.
    Gunzburg MJ; Ambaye ND; Del Borgo MP; Pero SC; Krag DN; Wilce MC; Wilce JA
    J Mol Recognit; 2012 Jan; 25(1):57-67. PubMed ID: 22213451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
    Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
    Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain.
    Li P; Peach ML; Zhang M; Liu H; Yang D; Nicklaus M; Roller PP
    Bioorg Med Chem Lett; 2003 Mar; 13(5):895-9. PubMed ID: 12617916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
    Long YQ; Guo R; Luo JH; Yang D; Roller PP
    Biochem Biophys Res Commun; 2003 Oct; 310(2):334-40. PubMed ID: 14521914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
    Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
    Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of Grb2 SH2 Domain Proteins for Mirror-Image Screening Systems.
    Noguchi T; Ishiba H; Honda K; Kondoh Y; Osada H; Ohno H; Fujii N; Oishi S
    Bioconjug Chem; 2017 Feb; 28(2):609-619. PubMed ID: 28032751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant compensatory role of position Y-2 conferring high affinity to non-phosphorylated inhibitors of Grb2-SH2 domain.
    Long YQ; Voigt JH; Lung FD; King CR; Roller PP
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2267-72. PubMed ID: 10465559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor.
    Gao Y; Voigt J; Wu JX; Yang D; Burke TR
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1889-92. PubMed ID: 11459654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based exploration of cyclic dipeptide chitinase inhibitors.
    Houston DR; Synstad B; Eijsink VG; Stark MJ; Eggleston IM; van Aalten DM
    J Med Chem; 2004 Nov; 47(23):5713-20. PubMed ID: 15509170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unambiguous Stereochemical Assignment of Cyclo(Phe-Pro), Cyclo(Leu-Pro), and Cyclo(Val-Pro) by Electronic Circular Dichroic Spectroscopy.
    Domzalski A; Margent L; Vigo V; Dewan F; Pilarsetty NVK; Xu Y; Kawamura A
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concise and enantioselective synthesis of Fmoc-Pmp(But)2-OH and design of potent Pmp-containing Grb2-SH2 domain antagonists.
    Li P; Zhang M; Peach ML; Liu H; Yang D; Roller PP
    Org Lett; 2003 Aug; 5(17):3095-8. PubMed ID: 12916990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src).
    Wang W; Ramdas L; Sun G; Ke S; Obeyesekere NU; Budde RJ; McMurray JS
    Biochemistry; 2000 May; 39(17):5221-8. PubMed ID: 10819990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1).
    Ettmayer P; France D; Gounarides J; Jarosinski M; Martin MS; Rondeau JM; Sabio M; Topiol S; Weidmann B; Zurini M; Bair KW
    J Med Chem; 1999 Mar; 42(6):971-80. PubMed ID: 10090780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics.
    Li P; Zhang M; Long YQ; Peach ML; Liu H; Yang D; Nicklaus M; Roller PP
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2173-7. PubMed ID: 12798329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.
    Papaioannou D; Geibel S; Kunze MB; Kay CW; Waksman G
    Protein Sci; 2016 Mar; 25(3):627-37. PubMed ID: 26645482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.
    Lung FD; Tsai JY
    Biopolymers; 2003; 71(2):132-40. PubMed ID: 12767115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation.
    Dekker FJ; de Mol NJ; Fischer MJ; Kemmink J; Liskamp RM
    Org Biomol Chem; 2003 Oct; 1(19):3297-303. PubMed ID: 14584793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.